These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 8708647)

  • 1. Lasting reduction of severe spasticity after ending chronic treatment with intrathecal baclofen.
    Dressnandt J; Conrad B
    J Neurol Neurosurg Psychiatry; 1996 Feb; 60(2):168-73. PubMed ID: 8708647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of severe spasticity treatment with intrathecal Baclofen in multiple sclerosis patients: Long term follow-up.
    Stampacchia G; Gerini A; Mazzoleni S
    NeuroRehabilitation; 2016 Apr; 38(4):385-93. PubMed ID: 27061166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of spasticity related to multiple sclerosis with intrathecal baclofen: a long-term follow-up.
    Rekand T; Grønning M
    J Rehabil Med; 2011 May; 43(6):511-4. PubMed ID: 21533331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrathecal baclofen for treatment of intractable spinal spasticity.
    Abel NA; Smith RA
    Arch Phys Med Rehabil; 1994 Jan; 75(1):54-8. PubMed ID: 8291963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathecal baclofen in multiple sclerosis and spinal cord injury: complications and long-term dosage evolution.
    Draulans N; Vermeersch K; Degraeuwe B; Meurrens T; Peers K; Nuttin B; Kiekens C
    Clin Rehabil; 2013 Dec; 27(12):1137-43. PubMed ID: 23858524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of intrathecal baclofen on electrical muscle activity in spasticity.
    Müller H; Zierski J; Dralle D; Börner U; Hoffmann O
    J Neurol; 1987 Jun; 234(5):348-52. PubMed ID: 3612208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study.
    Coffey JR; Cahill D; Steers W; Park TS; Ordia J; Meythaler J; Herman R; Shetter AG; Levy R; Gill B
    J Neurosurg; 1993 Feb; 78(2):226-32. PubMed ID: 8421205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrathecal baclofen for severe spasticity secondary to spinal cord injury.
    Lewis KS; Mueller WM
    Ann Pharmacother; 1993 Jun; 27(6):767-74. PubMed ID: 8329801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Continuous intrathecal infusion of baclofen. A new therapeutic method for spasticity].
    Berg-Johnsen J; Røste GK; Solgaard T; Lundar T
    Tidsskr Nor Laegeforen; 1998 Sep; 118(21):3256-60. PubMed ID: 9772811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic intrathecal baclofen administration for control of severe spasticity.
    Lazorthes Y; Sallerin-Caute B; Verdie JC; Bastide R; Carillo JP
    J Neurosurg; 1990 Mar; 72(3):393-402. PubMed ID: 2303874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous intrathecal infusion of baclofen in patients with spasticity caused by spinal cord injuries.
    Korenkov AI; Niendorf WR; Darwish N; Glaeser E; Gaab MR
    Neurosurg Rev; 2002 Aug; 25(4):228-30. PubMed ID: 12172730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathecal application of baclofen in the treatment of spasticity.
    Siegfried J; Rea GL
    Acta Neurochir Suppl (Wien); 1987; 39():121-3. PubMed ID: 3478975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecal baclofen for long-term treatment of spasticity: a multi-centre study.
    Ochs G; Struppler A; Meyerson BA; Linderoth B; Gybels J; Gardner BP; Teddy P; Jamous A; Weinmann P
    J Neurol Neurosurg Psychiatry; 1989 Aug; 52(8):933-9. PubMed ID: 2487035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term intrathecal baclofen infusion for treatment of spasticity.
    Penn RD; Kroin JS
    J Neurosurg; 1987 Feb; 66(2):181-5. PubMed ID: 3806200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrathecal baclofen for severe spinal spasticity.
    Penn RD; Savoy SM; Corcos D; Latash M; Gottlieb G; Parke B; Kroin JS
    N Engl J Med; 1989 Jun; 320(23):1517-21. PubMed ID: 2657424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A benefit-risk assessment of baclofen in severe spinal spasticity.
    Dario A; Tomei G
    Drug Saf; 2004; 27(11):799-818. PubMed ID: 15350152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic intrathecal baclofen in severely disabling spasticity: selection, clinical assessment and long-term benefit.
    Pirotte B; Heilporn A; Joffroy A; Zegers de Beyl D; Wesel P; Brotchi J; Levivier M
    Acta Neurol Belg; 1995 Dec; 95(4):216-25. PubMed ID: 8553795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous infusion of intrathecal baclofen: long-term effects on spasticity in spinal cord injury.
    Loubser PG; Narayan RK; Sandin KJ; Donovan WH; Russell KD
    Paraplegia; 1991 Jan; 29(1):48-64. PubMed ID: 2023770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of tolerance to baclofen in treatment of severe spasticity with intrathecal baclofen.
    Nielsen JF; Hansen HJ; Sunde N; Christensen JJ
    Clin Neurol Neurosurg; 2002 May; 104(2):142-5. PubMed ID: 11932045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indication, efficiency and complications of intrathecal pump supported baclofen treatment in spinal spasticity.
    Saltuari L; Kronenberg M; Marosi MJ; Kofler M; Russegger L; Rifici C; Bramanti P; Gerstenbrand F
    Acta Neurol (Napoli); 1992 Jun; 14(3):187-94. PubMed ID: 1442217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.